Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury

• Published in: Pediatric research Vol. 46; no. 5; pp. 543 - 547
• Main Authors: JUUL, S. E, STALLINGS, S. A, CHRISTENSEN, R. D
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 01.11.1999
• Subjects: Asphyxia Neonatorum - cerebrospinal fluid; Biological and medical sciences; Brain Injuries - cerebrospinal fluid; Cerebral Ventricles - blood supply; Erythropoietin - cerebrospinal fluid; Female; Humans; Infant, Newborn; Injuries of the nervous system and the skull. Diseases due to physical agents; Intracranial Hemorrhages - cerebrospinal fluid; Linear Models; Medical sciences; Meningitis - cerebrospinal fluid; Postpartum Hemorrhage - cerebrospinal fluid; Pregnancy; Traumas. Diseases due to physical agents; Human; Nervous system diseases; Erythropoietin; Cardiovascular disease; Cerebral ventricle; Concentration; Cerebrospinal fluid; Glycoprotein hormone; Hemorrhage; Vascular disease; Newborn; Central nervous system disease; Hypoxia; Meningitis; Cerebrovascular disease
• ISSN: 0031-3998; 1530-0447
• DOI: 10.1203/00006450-199911000-00009

We previously reported that erythropoietin (Epo) is present in human cerebrospinal fluid (CSF). It is not known whether CSF Epo concentrations change under conditions of CNS injury or, if so, whether this change reflects loss of blood-brain barrier integrity or increased CNS Epo synthesis. We hypothesized that CSF Epo increases in conditions of neural injury including hypoxia, meningitis, and intraventricular hemorrhage (IVH) and that CSF Epo concentrations are independent of plasma Epo concentrations. To test these hypotheses, Epo concentrations were measured in 122 paired CSF and blood samples obtained from neonates and children categorized as follows: 16, asphyxia; 31, meningitis; 11, IVH; 41, controls. Twelve infants treated with recombinant Epo (rEpo) and 11 additional samples from children with miscellaneous neurologic problems were also evaluated. CSF and plasma Epo concentrations were significantly higher in asphyxiated infants than in controls (225.0+/-155.0 versus 4.5+/-0.5 mU/mL; mean +/- SEM, p < 0.05, respectively, in CSF; 1806.7+/-1254 versus 5.2+/-0.5, p < 0.05 in plasma). Neonates with IVH had higher CSF Epo concentrations than controls (p < 0.01) but did not have higher plasma Epo concentrations than controls. Patients with meningitis did not have elevated CSF or plasma Epo concentrations. There was no correlation between CSF and plasma Epo concentrations in infants treated with rEpo. We conclude that Epo is selectively increased in the CSF by hypoxia, less so by IVH, and not at all by meningitis. rEpo treatment does not elevate CSF Epo. These findings suggest that rEpo does not cross the blood-brain barrier and that hypoxia induces increased CNS synthesis of Epo.